Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections

RK Shields, DL Paterson… - Clinical Infectious …, 2023 - academic.oup.com
… highlight a broader challenge of identifying effective treatment for CRAB … antibacterial agents
for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections

Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents

A Provenzani, AR Hospodar, AL Meyer… - International Journal of …, 2020 - Springer
… Unfortunately, challenges with new antibiotic discovery and … antimicrobial with activity against
Acinetobacter baumannii, … Ftortiazinon is a new antimicrobial agent administered as 300 …

[HTML][HTML] Addressing the challenges in antisepsis: focus on povidone iodine

R Barreto, B Barrois, J Lambert… - … of antimicrobial agents, 2020 - Elsevier
… can promote healing by preventing and treating infection. … was used to identify recent advances
and challenges in topical … Pseudomonas aeruginosa, XDR Acinetobacter baumannii and …

[PDF][PDF] … molecular detection of metallo-beta-lactamase genes among imipenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from …

…, A Pormohammad, A Hashemi - … of Clinical Infectious …, 2016 - brieflands.com
Treatment of wound infections is a challenge due to the biofilms formation and resistance to
antibiotics (5). Also, … Therefore, identifying carbapenem resistant strains and infection control …

[HTML][HTML] … agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in …

PY Liu, WC Ko, WS Lee, PL Lu, YH Chen… - … and Infection, 2022 - Elsevier
… development of new antimicrobial agents is essential. Novel … Species identification was
performed at each site and … challenge to global health. There is a great need to optimize …

Clinical perspective of antimicrobial resistance in bacteria

Y Zhu, WE Huang, Q Yang - Infection and drug resistance, 2022 - Taylor & Francis
… most important antibacterial agents for multidrug-resistant infections of gram-… Acinetobacter
baumannii and Pseudomonas aeruginosa may gradually turn into a major clinical challenge

[HTML][HTML] … colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend

A Balkhair, Z Al-Muharrmi, B Al'Adawi… - … Journal of Infectious …, 2019 - Elsevier
… that this finding presents an unprecedented challenge to … aeruginosa blood isolates is
particularly challenging since … resistant to all known antipseudomonal agents (data not shown). …

… -17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro …

N Farzi, M Oloomi, G Bahramali, SD Siadat… - … and Antimicrobial …, 2024 - Springer
… Thus, it is important to find novel antimicrobial agents with high … as antimicrobial agents
[60]. As shown, the synthetic Scolopendin had α-helical characteristics, which are challenging for …

[PDF][PDF] Antimicrobial resistance mechanisms in Pseudomonas aeruginosa

NM Moore, ML Flaws - Clinical Laboratory Science, 2011 - researchgate.net
aeruginosa may be treated with antimicrobial agents from … increasing challenge to hospitals,
both in the clinical treatment … , several genes have been identified that when mutated confer …

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

L Dijkshoorn, A Nemec, H Seifert - Nature reviews microbiology, 2007 - nature.com
antimicrobial agents and many resistance mechanisms have been … These problems have
led to the development of genotypic … bacteria, in particular Pseudomonas aeruginosa and A. …